Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2026-05-14 @ 8:54 PM
Study NCT ID:
NCT05007769
Status:
WITHDRAWN
Last Update Posted:
2021-11-05
First Post:
2021-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC
Sponsor:
Organization: